71 evolution "https:" "https:" "https:" "https:" "VIB" PhD scholarships at Nature Careers
Sort by
Refine Your Search
-
Listed
-
Country
-
Field
-
(FNR) and the partner institutions. Our DTU focuses on microbiome-mediated pathogenesis through microbiology and big data analytics. The programme offers transferable skills training, career development
-
The Bernhard Nocht Institute for Tropical Medicine (http://www.bnitm.de/en ) is the largest Research Institute for Tropical Medicine in Germany and is the National Reference Centre for Tropical
-
ATMPs via the European Medicines Agency: https://www.ema.europa.eu/en/human-regulatory-overview/advanced-therapy-medicinal-products-overview If you are curious, internationally minded, and driven by a
-
is accessible online: https://www.tec21.fr/phd-tec21 What we offer : 7 fully funded PhD positions with employment contract, competitive salary (monthly estimate net salary between 2 050 and 2 150 EUR
-
development support. Qualifications Specific Requirements MSc in Pharmacy; Experience with amino acid transporters; Experience with pharmaceutical application of drug transporters; Strong motivation and
-
. Benefits and salary The successful candidates will receive an attractive salary in accordance with the MSCA regulations for Early-Stage Researchers (http://ec.europa.eu/research/mariecurieactions
-
on the evolution of gene regulatory networks and Wnt pathway functions in emerging model organisms (e. g. insects, annelids, snails, flatworms, cnidarians), utilizing ‘omics technologies and bioinformatics. Students
-
publication-based PhD qualification, including: - Review of previous literature and the relevant theoretical background - Analysis of existing/secondary survey dataset(s) - Development of new survey and
-
well as multifold training and support for PhD students in framework of ISAS and the Leibniz association Training and scientific development opportunities in an international environment and an excellent working
-
the development of scalable software tools and pipelines, potentially leveraging GPU/FPGA accelerators. Our aim is to build next-generation molecular atlases for chronic diseases and to improve patient